|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The effects of two phasic oral contraceptives on hemostasis and platelet |
| Weinges KF; Wenzel E; Hellstern P; Geurts TB; Dieben TO |
| ADVANCES IN CONTRACEPTION. 1995 Sep;11(3):227-37. |
| At the University of Saarland, Homburg/Saar, Germany, researchers randomly assigned 20 women to either the group |
| using the new combiphasic oral contraceptive (OC) containing ethinyl estradiol (EE) and desogestrel (DSG) or the |
| group using a triphasic OC containing EE and levonorgestrel (LNG) to compare the two OCs' effects on hemostatic |
| parameters and platelet function. The EE dose in both OCs was comparable. The parameters were coagulation |
| parameters, anticoagulation parameters, fibrinolysis parameters, and platelet function parameters. Use of both the |
| combiphasic DSG/EE and the triphasic LNG/EE caused a modest activation of some parameters of coagulation and |
| fibrinolysis pathways and may have caused inhibition of antifibrinolysis. The triphasic LNG/EE modestly impaired |
| anticoagulation. Some of these changes were still evident during the posttreatment cycle, but to a lesser degree. |
| During treatment, all mean values stayed within the normal range. Neither OC affected platelet function. The |
| DSG/EE OC was associated with significantly higher levels of Factor VII and of plasma antithrombin-III than the |
| LNG/EE OC during the treatment period. During the post-treatment cycle, it was associated with significantly higher |
| plasma antithrombin-III and plasminogen activity and levels of plasma antithrombin-III and of Factor X. These |
| findings suggest that neither the combiphasic DSG/EE nor the triphasic LNG/EE clinically affected the overall |
| hemostatic balance. (PubHealth.info Document ID: CONT2T 2571-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The effects of two phasic oral contraceptives on |
| hemostasis and platelet function.", is(are) Weinges KF; Wenzel E; Hellstern P; Geurts TB; Dieben TO. The |
| source of this article is "ADVANCES IN CONTRACEPTION. 1995 Sep;11(3):227-37.". This article was published in |
| 1995 in English language(s). (PubHealth.info® Document ID: CONT2T 2571-06. All rights reserved with |
| PubHealth.info) PIN: 7571 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |